Schonfeld Strategic Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.54M | Sell |
141,306
-172,625
| -55% | -$9.21M | 0.05% | 377 |
|
|
2025
Q1 | $12.7M | Buy |
313,931
+51,636
| +20% | +$2.09M | 0.08% | 230 |
|
|
2024
Q4 | $7.3M | Sell |
262,295
-16,028
| -6% | -$446K | 0.04% | 363 |
|
|
2024
Q3 | $7.99M | Sell |
278,323
-163,471
| -37% | -$4.69M | 0.05% | 297 |
|
|
2024
Q2 | $10.4M | Sell |
441,794
-253,929
| -36% | -$5.96M | 0.07% | 293 |
|
|
2024
Q1 | $17.6M | Buy |
695,723
+561,371
| +418% | +$14.2M | 0.12% | 183 |
|
|
2023
Q4 | $3.14M | Sell |
134,352
-77,656
| -37% | -$1.81M | 0.02% | 599 |
|
|
2023
Q3 | $10.7M | Buy |
212,008
+36,808
| +21% | +$1.86M | 0.08% | 293 |
|
|
2023
Q2 | $8.18M | Buy |
175,200
+115,522
| +194% | +$5.39M | 0.07% | 389 |
|
|
2023
Q1 | $2.28M | Sell |
59,678
-38,478
| -39% | -$1.47M | 0.02% | 653 |
|
|
2022
Q4 | $5.38M | Buy |
98,156
+89,256
| +1,003% | +$4.89M | 0.04% | 457 |
|
|
2022
Q3 | $303K | Sell |
8,900
-15,000
| -63% | -$511K | ﹤0.01% | 2033 |
|
|
2022
Q2 | $225K | Buy |
+23,900
| New | +$225K | ﹤0.01% | 1750 |
|